This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie policy for more information on the cookies we use and how to delete or block them.

Ok, Got It
News, stories and opinions for the business innovators of the world.

Life Sciences.

Silicon Valley start-up Levitas Bio has launched the world’s first label-free cell separation platform, the LeviCell™.

Suraya SalehMarketing Communications Manager
Topics.

If your digital health strategy isn’t driving earnings or learnings, what is it doing?

From start-ups to established companies, almost everyone in the life sciences and diagnostics industries is playing with digital health in one form or another. But how do you ensure this investment translates into commercial success for your company?

Cole-Parmer puts user experience at the forefront with new peristaltic pump series

Cole-Parmer’s new Masterflex® Ismatec® Reglo Digital Pump series, is not so much an evolution, but a revolution of the popular peristaltic pump range.

IDEX Health & Science launches Tridex™ Protein Analyzer for bioprocessing

IDEX Health & Science has launched the Tridex™ Protein Analyzer, which Planet Innovation helped develop, to measure protein titer directly from a bioreactor in real time.

PI to manufacture Scinogy’s new cell processing system for cell therapy manufacture

Planet Innovation is partnering with Melbourne-based start-up Scinogy to manufacture a revolutionary new cell processing system that is being commercialized by global biotechnology company Thermo Fisher Scientific.

AusBiotech 2018: Putting digital health development under the spotlight

The AusBiotech National Conference, held in sunny Brisbane, brought together national and international leaders from across the life sciences industry. I took the opportunity to pop into a number of sessions on the growing AI and digital health sectors.

Genea’s IVF deal with Merck secures manufacturing contract for PI

Pharmaceutical giant Merck Serono has signed an exclusive deal securing global marketing and commercialization rights to Genea Biomedx’s range of IVF products including Gavi and Geri, which were designed by Genea with development partner, Planet Innovation.

Genea CEO: From idea to Product of the Year

Tomas Stojanov has been an integral part of an extremely successful network of invitro-fertilisation (IVF) clinics in his role as the CEO of fertility group Genea, but his personal dream is to do more. He wanted to change the world of IVF to benefit his company, his industry and most importantly his patients.

Sign up for the Perspectives newsletter:

A roundup of the latest news and opinions from PI.

How Genea changed the world of IVF through automation

Despite 30 years of IVF practice the process of freezing human embryos, known as vitrification, has remained extremely manual and susceptible to errors and inconsistencies by embryologists. In 2009, Genea Biomedx teamed up with Planet Innovation to solve this challenge by automating IVF vitrification and finally making the process consistent and standardised for labs around the world.